A detailed history of Sunpointe, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sunpointe, LLC holds 4,613 shares of MRK stock, worth $457,517. This represents 0.43% of its overall portfolio holdings.

Number of Shares
4,613
Previous 4,713 2.12%
Holding current value
$457,517
Previous $587 Million 10.17%
% of portfolio
0.43%
Previous 0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$111.15 - $128.97 $11,115 - $12,897
-100 Reduced 2.12%
4,613 $527 Million
Q2 2024

Jul 19, 2024

BUY
$123.8 - $132.96 $21,541 - $23,135
174 Added 3.83%
4,713 $587 Million
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $46,088 - $53,703
407 Added 9.85%
4,539 $602 Million
Q4 2023

Feb 20, 2024

BUY
$100.18 - $109.02 $413,943 - $450,470
4,132 New
4,132 $454 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.